Search hospitals > British Columbia > VANCOUVER
Vancouver General Hospital
Claim this profileVANCOUVER, British Columbia V5Z 1M9
Global Leader in Stroke
Global Leader in Leukemia
Conducts research for Heart Attack
Conducts research for Myocardial Infarction or Heart Attack
Conducts research for Heart Failure
290 reported clinical trials
30 medical researchers
Summary
Vancouver General Hospital is a medical facility located in VANCOUVER, British Columbia. This center is recognized for care of Stroke, Leukemia, Heart Attack, Myocardial Infarction or Heart Attack, Heart Failure and other specialties. Vancouver General Hospital is involved with conducting 290 clinical trials across 389 conditions. There are 30 research doctors associated with this hospital, such as David A Wood, MD, Ben Chew, MD, Jacqueline Saw, MD, and Thalia Field, MD.Area of expertise
1Stroke
Global Leader2Leukemia
Global LeaderCD19 positive
DSA negative
CD22 positive
Top PIs
David A Wood, MDVancouver General Hospital6 years of reported clinical research
Studies Aortic Stenosis
Studies Aortic Valve Stenosis
7 reported clinical trials
11 drugs studied
Ben Chew, MDVancouver General Hospital1 year of reported clinical research
Studies Kidney Stones
Studies Crohn's Disease
4 reported clinical trials
5 drugs studied
Jacqueline Saw, MDVancouver General Hospital4 years of reported clinical research
Studies Coronary Artery Anomalies
Studies Dissecting Aneurysm
4 reported clinical trials
7 drugs studied
Thalia Field, MDVancouver General Hospital6 years of reported clinical research
Studies Stroke
Studies Heart Disease
4 reported clinical trials
6 drugs studied
Clinical Trials running at Vancouver General Hospital
Stroke
Spinal Cord Injury
Hypercholesterolemia
Opioid Use Disorder
Traumatic Brain Injury
Oral Cancers
Prostate Cancer
Atrial Fibrillation
Wounds and Injuries
High Cholesterol
Milvexian
for Stroke
This trial is testing whether milvexian can help prevent another stroke in people who have already had one by stopping blood clots from forming. Milvexian may reduce the risk of stroke without significant bleeding.
Recruiting1 award Phase 35 criteria
AMPLATZER PFO Occluder
for Patent Foramen Ovale
The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZERâ„¢ PFO Occluder in the post Approval Setting.
Recruiting1 award N/A1 criteria
rFVIIa
for Hemorrhagic Stroke
The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is that rFVIIa, administered within 120 minutes from stroke onset with an identified subgroup of patients most likely to benefit, will improve outcomes at 180 days as measured by the Modified Rankin Score (mRS) and decrease ongoing bleeding as compared to standard therapy.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Vancouver General Hospital?
Vancouver General Hospital is a medical facility located in VANCOUVER, British Columbia. This center is recognized for care of Stroke, Leukemia, Heart Attack, Myocardial Infarction or Heart Attack, Heart Failure and other specialties. Vancouver General Hospital is involved with conducting 290 clinical trials across 389 conditions. There are 30 research doctors associated with this hospital, such as David A Wood, MD, Ben Chew, MD, Jacqueline Saw, MD, and Thalia Field, MD.